Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.1T | 4.6T | 4.5T | 4.0T |
Cost of revenue | 3.4T | 3.8T | 3.7T | 3.3T |
Gross profit | 705.4B | 741.3B | 726.1B | 658.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 144.9B | 143.6B | 144.9B | 127.0B |
Other operating expenses | 97.6B | 148.0B | 100.9B | 85.6B |
Operating income | 99.4B | 153.2B | 144.3B | 128.5B |
Non operating interest income | ||||
Income | 479.4M | 1.1B | 586.2M | 512.0M |
Expense | 83.8B | 92.0B | 79.5B | 78.0B |
Other income expense | — | — | — | — |
Pretax income | 6.4B | 66.5B | 72.0B | 37.8B |
Tax provision | -2.9M | 12.0B | 15.5B | 8.1B |
Net income | 6.4B | 54.5B | 56.5B | 29.8B |
Basic EPS | 0.8 | — | — | — |
Diluted EPS | 0.8 | — | — | — |
Basic average shares | 5.7B | — | — | — |
Diluted average shares | 5.7B | — | — | — |
EBITDA | 209.6B | 290.1B | 250.9B | 205.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -2.1B | -635.1M | -5.9B | -3.2B |
Preferred stock dividends | 0 | 0 | 0 | 0 |